Shinji Kondo
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment 9
-
- Neuroscience and Neuropharmacology Research 10
- Biological Psychiatry top 10%
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid 5
- Cancer Research top 10%
- MicroRNA in disease regulation 3
-
- Autophagy in Disease and Therapy 4
-
- Glioma Diagnosis and Treatment 3
-
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Intracerebral and Subarachnoid Hemorrhage Research 3
Shinji Kondo
54 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Psychiatry and Mental health 311
- Cellular and Molecular Neuroscience 322
- Biological Psychiatry 37
- Nephrology 95
- Cancer Research 170
Countries citing papers authored by Shinji Kondo
This map shows the geographic impact of Shinji Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinji Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinji Kondo more than expected).
Fields of papers citing papers by Shinji Kondo
This network shows the impact of papers produced by Shinji Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinji Kondo. The network helps show where Shinji Kondo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shinji Kondo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 9 | |
| 4 | 2023 | 22 | |
| 5 | 2022 | 2 | |
| 6 | 2017 | 22 | |
| 7 | 2016 | 3 | |
| 8 | 2013 | 6 | |
| 9 | 2012 | 115 | |
| 10 | 2010 | 160 | |
| 11 | 2008 | 17 | |
| 12 | 2007 | 13 | |
| 13 | 2004 | 4 | |
| 14 | 2003 | 22 | |
| 15 | 2001 | 44 | |
| 16 | 2001 | 65 | |
| 17 | 1999 | 24 | |
| 18 | 1996 | 11 | |
| 19 | 1988 | 52 | |
| 20 | 1988 | 1 |
About Shinji Kondo
Shinji Kondo is a scholar working on Cellular and Molecular Neuroscience, Nephrology and Psychiatry and Mental health, having authored 57 papers that have together received 1.5k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (10 papers), Epilepsy research and treatment (9 papers), Gout, Hyperuricemia, Uric Acid (5 papers), Autophagy in Disease and Therapy (4 papers), Glioma Diagnosis and Treatment (3 papers), MicroRNA in disease regulation (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Intracerebral and Subarachnoid Hemorrhage Research (3 papers). The work is most often cited by research in Psychiatry and Mental health (311 citations), Cellular and Molecular Neuroscience (322 citations) and Biological Psychiatry (37 citations). Shinji Kondo has collaborated with scholars based in Japan, Italy and United States. Frequent co-authors include Tomokatsu Hori, Hiroko Isoda, Takashi Watanabe, Atsumi Takenobu, Masamichi Kurosaki, Abdelfatteh El Omri, Sadaharu Tabuchi, Junkyu Han, Tadashi Komata and Yasuko Kondo.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.